How Is The Market Feeling About Edgewise Therapeutics?
Portfolio Pulse from Benzinga Insights
Edgewise Therapeutics (NYSE:EWTX) has seen a significant decrease in short interest, with a 58.78% drop since the last report. The current short interest stands at 8.17 million shares, representing 15.01% of the float. It would take about 7.63 days for traders to cover their short positions. While a decrease in short interest can indicate a more bullish sentiment, it does not necessarily predict a near-term rise in stock price. Edgewise has a higher short interest compared to its peers, with the average being 11.57%.
January 31, 2024 | 8:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Edgewise Therapeutics has experienced a significant decrease in short interest, which may suggest a more bullish sentiment among investors. However, this does not guarantee an immediate increase in stock price.
The substantial decrease in short interest for Edgewise Therapeutics indicates that investors may be less bearish on the stock, which could lead to a potential increase in its price in the short term. However, the market's complexity and other factors mean this isn't a definitive predictor of stock movement.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100